EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Xavier Ducrocq
Jean-Marie Wihlm
Gilbert Massard
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lemaitre, J.
Right arrow Articles by Massard, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lemaitre, J.
Right arrow Articles by Massard, G.
Related Collections
Right arrow Lung - cancer
Right arrow Trachea and bronchi

Eur J Cardiothorac Surg 2006;30:168-171
© 2006 Elsevier Science NL

Bronchoplastic lobectomy: do early results depend on the underlying pathology?

A comparison between typical carcinoids and primary lung cancer

Jean Lemaitre a , Ziad Mansour a , Evgenia A. Kochetkova a , Chawki Koriche a , Xavier Ducrocq a , Jean-Marie Wihlm a , Elisabeth Quoix b , Gilbert Massard a , *

a Service de Chirurgie thoracique, Hôpitaux universitaires de Strasbourg, 67091 Strasbourg, France
b Departement de pneumologie, Hôpitaux universitaires de Strasbourg, 67091 Strasbourg, France

Received 27 February 2006; received in revised form 23 March 2006; accepted 30 March 2006.

* Corresponding author. Tel.: +33 3 88 11 62 02; fax: +33 388 11 60 77. (Email: Gilbert.Massard{at}chru-strasbourg.fr).

Background: This study evaluates the impact of the underlying disease upon the surgical outcome of bronchoplastic lobectomy, comparing typical carcinoid tumours with primary lung carcinoma. Patients and methods: This retrospective study includes 98 consecutive patients (78 males, 20 females). Eighteen patients had a typical carcinoid tumour (group 1), and 80 had a primary bronchial carcinoma (group2). Fifty-six patients underwent bronchoplasty with full sleeve resection (10 patients from group 1, 46 from group 2) and 42 patients had a bronchoplasty with bronchial wedge resection (8 from group 1 and 34 from group 2). Right upper lobectomy was the most common procedure. We compared demographic data, surgical indications, the type of bronchoplasty and postoperative complications. Results: The average age in group 1 (38.5 ± 16.3 years; range 15–77) was significantly lower than in group 2 (61.4 ± 9.5 years; range 14–75) (p < 0.001). There were no postoperative deaths. Procedure-specific complications (anastomotic dehiscence and atelectasis) were found in 7 patients (8.75%) in group 2 (of which, three had a combination of two of the above-mentioned complications) but none (0%) in group 1 (p = 0.23). Seven patients from group 2 (8.75%) required treatment for a residual pneumothorax for none (0%) in group 1 (p = 0.23). The mean duration for air leak was comparable in both groups (p = 0.366). Three patients (16.67%) from group 1 had non-surgical complications compared to 17 (21.25%) in group 2 (of which, one had a combination of two non-surgical complications) (p = 0.35). Conclusion: Bronchoplastic resection is a safe operation in patients with carcinoid tumours and should be the reference for treatment.

Key Words: Carcinoid tumour • Lung cancer • Sleeve lobectomy







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.